The global powder hemostatic agent market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by factors such as increasing incidence of trauma and surgical procedures, rising geriatric population, and increasing awareness about the benefits of hemostatic agents in reducing blood loss and improving patient outcomes. Absorbable Hemostatic Agent segment accounted for the largest share in the global powder hemostatic agent market in 2017 owing to its ability to stop bleeding quickly and provide a long-lasting effect on clotting. Not Absorbable Hemostatic Agent segment is expected to grow at a higher CAGR during the forecast period due to its non-absorbability property which makes it suitable for use on sensitive areas such as mucous membranes or skin grafts where absorption may be undesirable or impossible. Hospitals accounted for the largest share in this market owing to their high usage rate among patients with severe bleeding disorders or injuries that require surgery or other invasive procedures. North America was estimated as one of the fastest growing regions in this market due to factors such as increased awareness about benefits of hemostatic agents, rising geriatric population, and increasing incidence rates of trauma and surgical procedures.
Some Of The Growth Factors Of This Market:
- The global population is increasing, which will lead to an increase in the number of people who are at risk for bleeding.
- The aging population will also lead to an increase in the number of people who are at risk for bleeding.
- Advances in medical technology have led to a decrease in mortality rates from hemorrhagic events, which has led to a greater need for hemostatic agents and treatments that can be used during these events.
- Advances in medical technology have also led to a decrease in mortality rates from traumatic injuries, which has led to a greater need for hemostatic agents and treatments that can be used during these events as well as other types of injuries such as burns or lacerations where there is significant blood loss or tissue damage that needs treatment before it becomes life-threatening or fatal due to blood loss or infection respectively.
- Advances in medical technology have also led to an increased use of surgical procedures, which leads directly into increased demand for hemostatic agents and treatments that can be used during these procedures.
Industry Growth Insights published a new data on “Powder Hemostatic Agent Market”. The research report is titled “Powder Hemostatic Agent Market research by Types (Absorbable Hemostatic Agent, Not Absorbable Hemostatic Agent), By Applications (Hospitals, Clinics, Home Care), By Players/Companies Johnson & Johnson(Ethicon), Celox Medical, Amed Therapeutics, Cryolife, BioCer Entwicklungs-GmbH, Yunnan Baiyao, HHAO TECHNOLOGY”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Powder Hemostatic Agent Market Research Report
By Type
Absorbable Hemostatic Agent, Not Absorbable Hemostatic Agent
By Application
Hospitals, Clinics, Home Care
By Companies
Johnson & Johnson(Ethicon), Celox Medical, Amed Therapeutics, Cryolife, BioCer Entwicklungs-GmbH, Yunnan Baiyao, HHAO TECHNOLOGY
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Powder Hemostatic Agent Market Report Segments:
The global Powder Hemostatic Agent market is segmented on the basis of:
Types
Absorbable Hemostatic Agent, Not Absorbable Hemostatic Agent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson(Ethicon)
- Celox Medical
- Amed Therapeutics
- Cryolife
- BioCer Entwicklungs-GmbH
- Yunnan Baiyao
- HHAO TECHNOLOGY
Highlights of The Powder Hemostatic Agent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Absorbable Hemostatic Agent
- Not Absorbable Hemostatic Agent
- By Application:
- Hospitals
- Clinics
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Powder Hemostatic Agent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Powder hemostatic agent is a medication that helps to stop bleeding. It is usually used to treat wounds or cuts. Powder hemostatic agents work by stopping the flow of blood and tissue fluids.
Some of the major players in the powder hemostatic agent market are Johnson & Johnson(Ethicon), Celox Medical, Amed Therapeutics, Cryolife, BioCer Entwicklungs-GmbH, Yunnan Baiyao, HHAO TECHNOLOGY.
The powder hemostatic agent market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Powder Hemostatic Agent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Powder Hemostatic Agent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Powder Hemostatic Agent Market - Supply Chain
4.5. Global Powder Hemostatic Agent Market Forecast
4.5.1. Powder Hemostatic Agent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Powder Hemostatic Agent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Powder Hemostatic Agent Market Absolute $ Opportunity
5. Global Powder Hemostatic Agent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Powder Hemostatic Agent Market Size and Volume Forecast by Type
5.3.1. Absorbable Hemostatic Agent
5.3.2. Not Absorbable Hemostatic Agent
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Powder Hemostatic Agent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Powder Hemostatic Agent Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Powder Hemostatic Agent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Powder Hemostatic Agent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Powder Hemostatic Agent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Powder Hemostatic Agent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Powder Hemostatic Agent Demand Share Forecast, 2019-2026
9. North America Powder Hemostatic Agent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Powder Hemostatic Agent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Powder Hemostatic Agent Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Powder Hemostatic Agent Market Size and Volume Forecast by Type
9.7.1. Absorbable Hemostatic Agent
9.7.2. Not Absorbable Hemostatic Agent
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Powder Hemostatic Agent Demand Share Forecast, 2019-2026
10. Latin America Powder Hemostatic Agent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Powder Hemostatic Agent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Powder Hemostatic Agent Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Powder Hemostatic Agent Market Size and Volume Forecast by Type
10.7.1. Absorbable Hemostatic Agent
10.7.2. Not Absorbable Hemostatic Agent
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Powder Hemostatic Agent Demand Share Forecast, 2019-2026
11. Europe Powder Hemostatic Agent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Powder Hemostatic Agent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Powder Hemostatic Agent Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Powder Hemostatic Agent Market Size and Volume Forecast by Type
11.7.1. Absorbable Hemostatic Agent
11.7.2. Not Absorbable Hemostatic Agent
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Powder Hemostatic Agent Demand Share, 2019-2026
12. Asia Pacific Powder Hemostatic Agent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Powder Hemostatic Agent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Powder Hemostatic Agent Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Powder Hemostatic Agent Market Size and Volume Forecast by Type
12.7.1. Absorbable Hemostatic Agent
12.7.2. Not Absorbable Hemostatic Agent
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Powder Hemostatic Agent Demand Share, 2019-2026
13. Middle East & Africa Powder Hemostatic Agent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Powder Hemostatic Agent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Powder Hemostatic Agent Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Powder Hemostatic Agent Market Size and Volume Forecast by Type
13.7.1. Absorbable Hemostatic Agent
13.7.2. Not Absorbable Hemostatic Agent
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Powder Hemostatic Agent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Powder Hemostatic Agent Market: Market Share Analysis
14.2. Powder Hemostatic Agent Distributors and Customers
14.3. Powder Hemostatic Agent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson(Ethicon)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Celox Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Amed Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cryolife
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioCer Entwicklungs-GmbH
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Yunnan Baiyao
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. HHAO TECHNOLOGY
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook